Delivery Order SPE2DB20D1004-SPE2DB23FG3Q7

Award Date 8/10/23
Potential Completion Date 8/11/23
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,566,305,374 units of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $3,857.40 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of November 4, 2024 and was not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award is for the delivery of 4,560,094 units of epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $1,945.56 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of 4,558,457,757 units of Epinephrine 0.3 mg Auto-Injectors. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award has a ceiling value of $3,775.92 and a completion date of September 15, 2022. This appears to be a delivery order against a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award is for the delivery of 4,562,163,672 units of Epinephrine 0.3 mg auto-injectors, awarded to AmerisourceBergen Drug Corp. The $5,053.63 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of September 14, 2023. This appears to be a child contract under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order to Amerisourcebergen Drug Corp for the supply of 4,566,166,872 units of 0.3 mg epinephrine auto-injectors. The $4,288.70 firm fixed-price contract has an ultimate completion date of October 22, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of 4,567,197,404 units of epinephrine 0.3 mg auto-injectors. The contract, valued at $23,186.88, was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 10, 2025 and is a firm fixed-price delivery order. There is no set-aside designation for this contract. AmerisourceBergen holds a larger...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,789,829 units of epinephrine 0.3 mg auto-injectors. The $2,532.43 firm fixed-price delivery order contract has a completion date of December 24, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is for the delivery of 4,564,260 units of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $2,990.60 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a division of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical for up to $999,999,999.00 through December...
This federal contract award is for the delivery of 4,566,049,084 units of epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,794.36, was awarded to Amerisourcebergen Drug Corp on October 8, 2024, with a completion date of October 9, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific socioeconomic program. Amerisourcebergen Drug Corp, a major...
This federal contract award is for the delivery of epinephrine 0.3 mg auto-injectors, valued at $1,856.40. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FG3Q7
    Delivery Order

This federal contract award is for the delivery of 4,561,769,762 units of Epinephrine 0.3 mg auto-injectors. The $2,242.95 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of August 11, 2023. This award is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This contract supports the medical needs of military personnel, veterans, and other federal beneficiaries through the efficient procurement of essential pharmaceutical products.

Generated 2/27/25, 11:52 AM